Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
To date, hypolipidemic drugs of the statin group are among the most popular therapeutic agents used for the prevention and treatment of the most common worldwide atherosclerotic cardiovascular diseases (CVD). Therefore, considerable attention of researchers is focused on statins to study the additio...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Столичная издательская компания
2023-05-01
|
| Edice: | Рациональная фармакотерапия в кардиологии |
| Témata: | |
| On-line přístup: | https://www.rpcardio.online/jour/article/view/2764 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|